SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015068
Filing Date
2024-11-08
Accepted
2024-11-08 16:46:25
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fencf-20240930x10q.htm   iXBRL 10-Q 1701886
2 EX-31.1 fencf-20240930xex31d1.htm EX-31.1 13959
3 EX-31.2 fencf-20240930xex31d2.htm EX-31.2 18541
4 EX-32.1 fencf-20240930xex32d1.htm EX-32.1 9372
5 EX-99.1 fencf-20240930xex99d1.htm EX-99.1 213960
6 GRAPHIC fencf-20240930xex99d1001.jpg GRAPHIC 3171
  Complete submission text file 0001558370-24-015068.txt   7536125

Data Files

Seq Description Document Type Size
7 EX-101.SCH fencf-20240930.xsd EX-101.SCH 52689
8 EX-101.CAL fencf-20240930_cal.xml EX-101.CAL 38895
9 EX-101.DEF fencf-20240930_def.xml EX-101.DEF 210898
10 EX-101.LAB fencf-20240930_lab.xml EX-101.LAB 351374
11 EX-101.PRE fencf-20240930_pre.xml EX-101.PRE 328658
68 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20240930x10q_htm.xml XML 1342513
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 241441411
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)